Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announce that they have entered into distribution, license and supply agreements with Mundipharma and its network of independent associated companies granting exclusive rights to anamorelin in Norway, Finland, Sweden, Denmark and Iceland.

from News-Medical.Net Weight Loss News Feed http://ift.tt/1Wp2tPZ
Follow Us on Twitter
Follow Us on FB
Follow Us on Pinterest
Follow Us on G+
Follow Us on Instagram
Follow Us on Instagram
Follow Us on Delicious
Follow Us on Wordpress